tiprankstipranks
Biocept (BIOCQ)
OTHER OTC:BIOCQ
US Market

Biocept (BIOCQ) Financial Statements

Compare
1,247 Followers

Biocept Financial Overview

Biocept's market cap is currently $263.00. The company's EPS TTM is $; its P/E ratio is ―; Biocept is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 25.86M$ 61.25M$ 27.46M$ 5.53M
Gross Profit$ -2.58M$ 23.48M$ 6.12M$ -5.45M
Operating Income$ -31.98M$ -2.41M$ -15.47M$ -23.06M
EBITDA$ -30.24M$ -879.00K$ -16.57M$ -24.11M
Net Income$ -32.09M$ -2.82M$ -17.81M$ -25.14M
Balance Sheet
Cash & Short-Term Investments$ 12.90M$ 28.86M$ 14.37M$ 9.30M
Total Assets$ 30.87M$ 60.42M$ 47.45M$ 17.73M
Total Debt$ 12.11M$ 12.67M$ 12.23M$ 2.54M
Net Debt$ -788.00K$ -16.19M$ -2.14M$ -6.76M
Total Liabilities$ 22.01M$ 22.94M$ 23.76M$ 6.53M
Stockholders' Equity$ 8.86M$ 37.48M$ 23.69M$ 11.20M
Cash Flow
Free Cash Flow$ -14.10M$ 2.12M$ -20.65M$ -23.78M
Operating Cash Flow$ -13.29M$ 3.69M$ -19.79M$ -23.05M
Investing Cash Flow$ -807.00K$ -1.57M$ -866.81K$ -735.30K
Financing Cash Flow$ -1.87M$ 12.38M$ 25.72M$ 29.66M
Currency in USD

Biocept Earnings and Revenue History

Biocept Debt to Assets

Biocept Cash Flow

Biocept Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis